Beijing Eastwide

Eastwide (Beijing Eastwide Technology Co., Ltd.) is a specialized Contract Research Organization (CRO) based in China, primarily focused on clinical data management and biostatistics. Established in 2004, the company provides a suite of services including Electronic Data Capture (EDC), Interactive Web Response Systems (IWRS), and clinical trial reporting. It is recognized for its high-quality data standards and has supported numerous clinical trials for both domestic Chinese firms and international pharmaceutical companies. In 2018, Eastwide was acquired by dMed Biopharmaceutical to serve as the foundation for dMed's data capabilities. Following the 2021 merger between dMed and Clinipace, Eastwide's operations were integrated into the global CRO now known as Caidya. The company continues to play a vital role in providing data-driven solutions for complex clinical research projects across the Asia-Pacific region.